{"Q": 1, "answer": "no", "rationale": "The segment does not contain an intensifier or comparative directly modifying a risk-adjective.", "method": "llm_batch", "batch_id": "batch_1_1736", "batch_size": 200, "batch_pos": 51, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 2, "answer": "no", "rationale": "The segment does not contain a high-potency verb, potent metaphor, superlative + harm noun, intensifier + harm noun, or critical alert phrase.", "method": "llm_batch", "batch_id": "batch_2_17672", "batch_size": 200, "batch_pos": 23, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 3, "answer": "no", "rationale": "Segment does not contain a moderate verb paired with explicit scale or impact.", "method": "llm_batch", "batch_id": "batch_3_16476", "batch_size": 200, "batch_pos": 196, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 4, "answer": "no", "rationale": "The segment does not contain a loaded rhetorical question.", "method": "llm_batch", "batch_id": "batch_4_14360", "batch_size": 200, "batch_pos": 191, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 5, "answer": "no", "rationale": "Reports deal details; no explicit calming cue.", "method": "llm_batch", "batch_id": "batch_5_17440", "batch_size": 200, "batch_pos": 188, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 6, "answer": "no", "rationale": "Segment contains quantities but not a minimiser + scale contrast.", "method": "llm_batch", "batch_id": "batch_6_10636", "batch_size": 200, "batch_pos": 150, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 7, "answer": "no", "rationale": "The segment reports facts but contains no bare negation or explicit calming cue.", "method": "llm_batch", "batch_id": "batch_7_16840", "batch_size": 200, "batch_pos": 144, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
{"Q": 8, "answer": "yes", "rationale": "regex:CapabilityNoReassurance matched", "method": "regex", "batch_id": "batch_8_14860", "batch_size": 200, "batch_pos": 11, "regex": {"rule": "CapabilityNoReassurance", "span": [42, 49], "captures": []}, "statement_text": "The deal secures up to 665,000 doses from vaccine manufacturer CSL Seqirus and includes an option for a further 40 million vaccines for a maximum of four years.", "article_id": 1683}
